More info:

• Popular Products

  Viagra Cialis Viagra Professional Cialis Professional Amoxil Prednisolone Lasix Propecia Levitra

• Aciphex

  Aciphex (Rabeprazolo): Inibitore Selettivo della Pompa Protonica per il Controllo Acido Gastrico - Monografia Basata sull’Evidenza Aciphex, il cui principio attivo è il rabeprazolo sodico, rappresenta un cardine nella terapia soppressiva dell’acido gastrico. Appartiene alla classe degli inibitori della pompa protonica (PPI), farmaci che hanno rivoluzionato la gestione di una vasta gamma di disturbi acidi-correlati. A differenza degli antagonisti dei recettori H2, che bloccano solo uno dei percorsi di stimolazione della cellula parietale, gli IPP come Aciphex agiscono sullo step finale e comune della secrezione acida: la pompa protonica H+/K+ ATPasi.

• Brafix Cranial Orthosis: Evidence-Based Correction for Positional Plagiocephaly

  Product Description: Brafix is a Class IIa medical device, specifically a non-invasive cranial remolding orthosis, designed for the management of positional plagiocephaly, brachycephaly, and scaphocephaly in infants. It functions through the application of gentle, persistent pressure to guide cranial growth during a period of rapid development, promoting symmetrical skull formation. Its use is indicated when conservative repositioning therapy has proven insufficient, typically for infants aged 3 to 18 months with moderate to severe cranial deformation.

• Dutanol: Neuromodulation Therapy for Refractory Tinnitus - Evidence-Based Review

  Product Description: Dutanol is a non-invasive, Class IIa medical device designed for the symptomatic treatment of chronic, refractory tinnitus. It utilizes a precisely calibrated, low-intensity, alternating current electrical stimulation applied transcutaneously to the auricular branch of the vagus nerve (ABVN) and associated dermatomes of the external ear. The therapy aims to modulate aberrant neuronal activity within central auditory and non-auditory brain networks implicated in tinnitus perception. It is intended for use under the guidance of a qualified healthcare professional, typically within a structured therapeutic protocol.

• Keraglo Eva: A Multi-Target Topical Solution for Female Pattern Hair Loss - Evidence-Based Review

  Product Description: Keraglo Eva is a specialized topical medical device, presented as a spray or foam, designed for the comprehensive management of androgenetic alopecia (pattern hair loss) and telogen effluvium in women. Its formulation is built on a multi-target approach, combining key vasodilatory, anti-fibrotic, and hair cycle-modulating agents with a patented delivery system to optimize follicular penetration and patient adherence. Unlike monotherapies, it aims to address multiple pathophysiological pathways simultaneously.

• Pepcid: Effective Acid Suppression for GERD and Ulcer Disease - Evidence-Based Review

  Product Description: Pepcid is a well-established pharmaceutical agent, not a dietary supplement or medical device, belonging to the class of histamine-2 (H2) receptor antagonists. Its active pharmaceutical ingredient is famotidine. It functions by competitively inhibiting histamine at H2 receptors on gastric parietal cells, leading to a marked reduction in both the volume and concentration of gastric acid secretion. This monograph details its clinical pharmacology, therapeutic applications, and practical use considerations based on current evidence and extensive clinical experience.

• Prevacid: Potent Acid Suppression for GERD and Ulcer Healing - Evidence-Based Review

  Product Description: Prevacid is a proton pump inhibitor (PPI) medication, with the active ingredient lansoprazole. It is available in both prescription and over-the-counter (OTC) formulations. It works by profoundly and lastingly reducing the production of stomach acid. This monograph details its use in the management of acid-related disorders, based on clinical evidence and practical therapeutic experience. 1. Introduction: What is Prevacid? Its Role in Modern Acid Suppression Prevacid, generically known as lansoprazole, is a member of the proton pump inhibitor (PPI) class of drugs.

• Prilosec

  Prilosec (Omeprazolo): Inibitore della Pompa Protonica per il Controllo Acido Gastrico - Monografia Basata sull’Evidenza Prilosec, il cui principio attivo è l’omeprazolo, rappresenta una pietra miliare nella terapia acido-soppressiva. Appartiene alla classe degli inibitori della pompa protonica (IPP), farmaci che hanno rivoluzionato la gestione di una vasta gamma di disturbi gastrointestinali legati all’acidità. Commercializzato inizialmente dalla AstraZeneca, l’omeprazolo è stato il primo IPP introdotto nella pratica clinica, offrendo un controllo dell’acidità gastrica più potente e prolungato rispetto alle classi terapeutiche precedenti, come gli antagonisti dei recettori H2 dell’istamina.

• Protonix

  Protonix, known generically as pantoprazole, is a proton pump inhibitor (PPI) prescribed for the management of conditions related to gastric acid hypersecretion. It functions by irreversibly inhibiting the H+/K+ ATPase enzyme system—the “proton pump”—at the secretory surface of the gastric parietal cell. This action leads to a profound and prolonged suppression of basal and stimulated gastric acid production, regardless of the stimulus. It is a cornerstone therapy in gastroenterology for healing and symptomatic relief in acid-peptic disorders.

• Ranitidine

  Ranitidine, a histamine H2-receptor antagonist (H2RA), was for decades a cornerstone in the management of gastric acid-related disorders. From its introduction in the early 1980s, it offered a significant advancement over earlier antacids, providing longer-lasting and more predictable suppression of gastric acid secretion. It became one of the most widely prescribed medications globally, available both by prescription and, later, as an over-the-counter (OTC) product for heartburn and acid indigestion. Its story, however, took a dramatic turn in 2019-2020, making a thorough understanding of its pharmacology, uses, and the reasons for its market withdrawal essential for clinical practice and patient safety.